Expert Video - What’s the connection between MDS and AML-MRC?
Dr. Sandra Kurtin, expert on acute myeloid leukemia (AML), explains that myelodysplastic syndrome, or MDS, is also a disorder of abnormal cells in the blood and bone marrow. MDS can develop into AML-MRC because it is also a malignancy, or cancer, of the bone marrow cells. Having a higher-risk type of MDS raises the risk of developing AML later.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This activity is supported by educational grants from AbbVie, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.